Clinical Trial

Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease

Study acronym: COMPLETE-2
Recruiting
View on ClinicalTrials.gov →
Summary
COMPLETE-2 is a prospective, multi-centre, randomized controlled trial comparing a strategy of physiology-guided complete revascularization to angiography-guided complete revascularization in patients with acute ST-segment elevation myocardial infarction (STEMI) or non-ST-segment elevation myocardial infarction (NSTEMI) and multivessel coronary artery disease (CAD) who have undergone successful culprit lesion Percutaneous Coronary Intervention (PCI). COMPLETE-2 OCT is a large scale, prospective, multi-centre, observational, imaging study of patients with STEMI or NSTEMI and multivessel CAD in a subset of eligible COMPLETE-2 patients.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-01-25; most recent amendment 2025-06-16.
Status change: Not Yet Recruiting → Recruiting 2023-08-22
Trial Details
NCT Number NCT05701358
Lead Sponsor Population Health Research Institute
Conditions Acute Myocardial Infarction, Coronary Artery Disease
Enrollment 5,100 participants
Start Date 2023-06-22
Primary Completion 2028-06 (estimated)
Study Completion 2028-06 (estimated)
Updated on ClinicalTrials.gov 2025-06-19